Lawyers involved in the federal litigation over gadolinium-based contrast agents, which have been linked to the development of a debilitating condition known as Nephrogenic Systemic Fibrosis, are scheduled to meet with the Court today to discuss the process for selecting the first NSF lawsuits for trial and the status of the plaintiffs’ ability to identify which of the five different gadolinium contrast agents were used in each case. Continued
All Posts Tagged With: "NFD"
Nephrogenic Systemic Fibrosis Lawsuit
Gadolinium based contrast agents used during MRI and MRA tests could cause nephrogenic systemic fibrosis (NSF), also known as nephrogenic fibrosing dermopathy (NFD) for individuals with moderate to severe kidney problems. The devastating condition could have been avoided by hundreds of people throughout the United States if the manufacturers of these contrast agents had warned about the potential MRI problems. Continued
